STARHEALTH Star Health and Allied Insurance Company Q4 FY25 results (Jan–Mar 2025) and concall
Star Health closed FY25 with strong premium growth but faced significant pressure on profitability due to elevated claim ratios. The company is aggressively recalibrating its group business and implementing cohort-based pricing to manage loss ratios. Despite a 'bad year' for claims, management remains committed to a long-term vision of tripling profits by FY28 through digital transformation and agency expansion.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 4,058 | 4,146 | 4,081 |
| EBITDA | 147 | 285 | -7 |
| Net profit | 111 | 215 | 1 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
